← FDA Drug Approvals (Drugs@FDA)
DEXTROAMPHETAMINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TRIS PHARMA INC · Approved 2022-08-18
Drug application
- FDA Application #
ANDA206095- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEXTROAMPHETAMINE SULFATE
- Generic name
- DEXTROAMPHETAMINE SULFATE
- Active ingredients
- DEXTROAMPHETAMINE SULFATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TRIS PHARMA INC
- Manufacturer
- Cranbury Pharmaceuticals, LLC
- First approval
- 2022-08-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown